Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
  • Subscribe
Submit An Article

Opinion

  • Home
  •  
  • Opinion



  • Most Read
  • Latest Comments
  • The big shift in asset prices – Where to from here?
    • Opinion

    Is ASX: OOO the riskiest or smartest oil investment?
    Public
  • The big shift in asset prices – Where to from here?
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • The big shift in asset prices – Where to from here?
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • The big shift in asset prices – Where to from here?
    • Opinion

    Three Tech Stocks Under 10c Positioned to Capitalise on Global Coronavirus Shutdowns
    Public
  • The big shift in asset prices – Where to from here?
    Research Note - Rise of the Cashless Economy
    • Review
    • June 3, 2020
  • Three Tech Stocks Under 10c Positioned to Capitalise on Global Coronavirus Shutdowns
    • Review
    • March 13, 2020
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019
  • Does Paypal’s entry into the BNPL space mean trouble for Afterpay?
    • Review
    • September 1, 2020
  • The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    • Review
    • April 22, 2020

Latest Articles

  • July 2022 Economic Wrap and the ASX Stocks that Moved
    July 2022 Economic Wrap and the ASX Stocks that Moved
    • Opinion

  • Finally time to buy Tech and Discretionary stocks?
    Finally time to buy Tech and Discretionary stocks?
    • Opinion

  • Existential childcare crisis: G8 Education appoints discount retail boss as CEO
    Existential childcare crisis: G8 Education appoints discount retail boss as CEO
    • Opinion

  • Emerald Financial Research Note Update – Pharmaxis Ltd
    Emerald Financial Research Note Update - Pharmaxis Ltd
    • Opinion

  • Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?
    Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?
    • Opinion

  • The big shift in asset prices – Where to from here?
    • Opinion

    The big shift in asset prices – Where to from here?

    Investors in the past week, no doubt, would have come across a torrent of news reports on the selloff in global share markets, rising inflation & interest rates, and energy shortages on the east coast of Australia with a real possibility of ongoing blackouts. Therefore, investors can be forgiven for feeling a little anxious about

    Read More
    Public
  • Why Orthocell has blown my mind this morning
    • Opinion

    Why Orthocell has blown my mind this morning

    When I read Orthocell’s (ASX: OCC) company announcement I had to do a double take.  Why?  Because they are casually RESTORING FUNCTION TO PARALYSED LIMBS. Go back, read that again. Scoop your jaw off the floor.  That’s right, regenerative medicine company Orthocell (ASX: OCC) has received final data for their nerve reconstruction study were theyRead More
    Public
  • Emerald Financial Research Note – Harris Technology
    • Opinion

    Emerald Financial Research Note – Harris Technology

    Recently, the Advisors at Emerald Financial recently released a Buy report on Harris Technology (ASX: HT8). Key Highlights include: Q3 FY22 Sales Revenue of $12.6m, +23% YoY; YTD Sales Revenue to March 2022 of $41.2m, full year FY21 was $41.8m; Scale of operation established for transition toward margin focus; $1m NPAT in FY20 increased toRead More
    Public
  • The ASX listed biotech companies making their mark in oncology
    • Opinion

    The ASX listed biotech companies making their mark in oncology

    Balance sheets don’t tell the whole story. This is especially true for biotech companies where pre-revenue businesses can still be worth billions of dollars with the innovative medicines they are creating.  On a macro level, biotech companies outperformed the S&P 500 and both pharmaceutical and medtech sectors in terms of total returns to shareholders overRead More
    Public
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
    • Opinion

    Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap

    “Sorry, but what the f**k is the point of a first home buyers scheme if we need another first home buyers scheme to access it?” That was the question that came out of my best friend’s mouth whilst we waited for our post-pilates morning lattes today. It’s been bouncing around in my brain as IRead More
    Public
  • The inflation we need to have
    • Opinion

    The inflation we need to have

    A shrinking global labour pool will demand better wages and conditions, pushing up prices. This month I want to address a common question being asked by investors i.e. ‘how long could high and higher prices last’. The short answer is that a very, very long time. But there may be a silver lining here. Over the

    Read More
    Public
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

Copyright © 2020 The Sentiment. All rights reserved.